Ticker

Analyst Price Targets — ALX

Page 1 • Showing up to 10
DateAnalystFirmTargetPrice @ PostSourceHeadline
August 6, 2024 7:29 amAlexander GoldfarbPiper Sandler$125.00$217.11StreetInsider Alexander's (ALX) PT Lowered to $125 at Piper Sandler
May 13, 2024 10:14 amAlexander GoldfarbPiper Sandler$145.00$216.71StreetInsider Alexander's (ALX) PT Lowered to $145 at Piper Sandler

Latest News for ALX

ALX Oncology Reports Inducement Grant as permitted by the Nasdaq Listing Rules

SOUTH SAN FRANCISCO, Calif., June 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. ("ALX Oncology," Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend patients' lives, announced that the Compensation Committee of the Board of Directors of ALX Oncology approved the granting of an inducement stock option to purchase a total of…

GlobeNewsWire • Jun 30, 2026
Greenridge Exploration Fully Exercises Option for 100% Interest in the Carpenter Lake Uranium Project in Athabasca Basin, Saskatchewan

VANCOUVER, British Columbia, June 16, 2026 (GLOBE NEWSWIRE) -- Greenridge Exploration Inc. (“Greenridge” or the “Company”) (CSE: GXP | OTC: GXPLF | FRA: HW3), is pleased to announce that the Company has fulfilled all the obligations of its property option agreement (the “Agreement”) to earn a 100% legal and beneficial interest in the Carpenter Lake Uranium Project (“Carpenter Lake” or the “Project”), located on the…

GlobeNewsWire • Jun 16, 2026

🧮 Earnings Move Analyzer

Insider Trading

Insider Trading

NameRoleDateTypeSharesPriceFormLink

No Senate trades found for ALX.

No House trades found for ALX.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top